Title: Supplemental Treatment in View of Side Effects of Tamoxifen (G1113A)

Inventors: Göran Landberg, Maria Stendahl, Åsa Kronblad

Abstract
Tamoxifen, drug frequently used in post-operative treatment of breast cancer, can
have extremely negative side effects on some 15% of the patients.

Application
Diagnostic test based on the above should be standard procedure in all breast
cancer treatments.

Patent status
PCT-application pending

Licensing contact
Sten Trolle, CEO, Lund University Technology Group
sten.trolle@forskarpatent.com
Phone: +46 46 286 36 01

Keywords
tamoxifen, breast cancer treatment, diagnostic test